Novartis AG
Novartis AG (NVSEF) Stock Overview
Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
288.1B
P/E Ratio
20.55
EPS (TTM)
$7.15
ROE
0.33%
NVSEF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Novartis AG (NVSEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 40.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $155.68.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.55 and a market capitalization of 288.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.